WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark SENDA BIOSCIENCES was filed as Word mark on 03/19/2021 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1590070 |
| Countries | 
|
| Base trademark |
No. 90206885,
September 24, 2020
|
| Application date | March 19, 2021 |
| Expiration date | March 19, 2031 |
Trademark owner
20 Acorn Park Drive
Cambridge MA 02140
US
Cambridge MA 02140
US
Trademark representatives
600 Atlantic Avenue
Boston MA 02210-2206
US
goods and services
05
Therapeutic products for the treatment of disease;
pharmaceutical preparations for the treatment of disease;
therapeutic products to modulate metabolism; pharmaceutical
preparations and agents to modulate metabolism; agents that
modulate metabolism for scientific and research use;
therapeutic pharmaceuticals for the treatment of disease,
namely, autoimmune diseases and disorders, bone and joint
diseases and disorders, cancer, cardiovascular diseases and
disorders, gastro-intestinal diseases and disorders,
hematologic diseases and disorders, infectious diseases,
kidney diseases and disorders, lung diseases and disorders,
metabolic diseases and disorders, muscle diseases and
disorders, nephrology diseases and disorders,
neurodegenerative diseases and disorders, neurologic
diseases and disorders, ophthalmic disease and disorders,
skin diseases and disorders; pharmaceutical preparations for
the treatment of disease, namely, autoimmune diseases and
disorders, bone and joint diseases and disorders, cancer,
cardiovascular diseases and disorders, gastro-intestinal
diseases and disorders, hematologic diseases and disorders,
infectious diseases, kidney diseases and disorders, lung
diseases and disorders, metabolic diseases and disorders,
muscle diseases and disorders, nephrology diseases and
disorders, neurodegenerative diseases and disorders,
neurologic diseases and disorders, ophthalmic disease and
disorders, skin diseases and disorders; therapeutic
pharmaceuticals for modulating metabolism; pharmaceutical
preparations and agents to modulate metabolism;
pharmaceutical agents that modulate metabolism for
scientific and research use
42
Research and development in the field of computational
biology, biotechnology and pharmaceuticals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| January 17, 2023 | 2023/5 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 23, 2022 | 2022/48 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| August 31, 2022 | 2022/37 Gaz | BR | Rejection |
| August 26, 2022 | 2022/35 Gaz | CA | Rejection |
| July 7, 2022 | 2022/27 Gaz | MX | Rejection |
| May 17, 2022 | 2022/21 Gaz | BR | Rejection |
| May 2, 2022 | 2022/25 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 16, 2022 | 2022/17 Gaz | Deletion | |
| March 7, 2022 | 2022/10 Gaz | KR | Rejection |
| March 7, 2022 | 2022/10 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| February 24, 2022 | 2022/8 Gaz | JP | Rejection |
| February 15, 2022 | 2022/9 Gaz | IN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| January 31, 2022 | 2022/5 Gaz | CH | Rejection |
| November 30, 2021 | 2021/48 Gaz | NZ | Rejection |
| October 28, 2021 | 2021/44 Gaz | EM | Rejection |
| September 16, 2021 | 2021/37 Gaz | GB | Rejection |
| September 2, 2021 | 2021/37 Gaz | CN | Rejection |
| September 1, 2021 | 2021/37 Gaz | IL | Rejection |
| July 26, 2021 | 2021/30 Gaz | RU | Rejection |
| July 20, 2021 | 2021/29 Gaz | AU | Rejection |
| July 10, 2021 | 2021/29 Gaz | SG | Rejection |
| May 24, 2021 | 2021/22 Gaz | IN | Rejection |
| March 19, 2021 | 2021/16 Gaz | US | Registration |
ID: 141590070